{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:55:16Z","timestamp":1785862516994,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11046-023-00781-7","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T13:02:44Z","timestamp":1691499764000},"page":"693-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Itraconazole Serum Trough Concentrations Using Oral Capsules for the Treatment of Chronic Pulmonary Aspergillosis: What is the Target?"],"prefix":"10.1007","volume":"188","author":[{"given":"V\u00edtor Falc\u00e3o","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Ciampone","family":"Arcieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wdson Luis Lima","family":"Kruschewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Nathan","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo Jos\u00e9 Co\u00ealho","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschoalina","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio","family":"de Almeida Rezende Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Satie Gon\u00e7alves Kono","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Abdala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Mihailenko Chaves","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"issue":"6","key":"781_CR1","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1378\/chest.121.6.1988","volume":"121","author":"AO Soubani","year":"2002","unstructured":"Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121(6):1988\u201399. https:\/\/doi.org\/10.1378\/chest.121.6.1988.","journal-title":"Chest"},{"issue":"Supplement_2","key":"781_CR2","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1093\/mmy\/myy070","volume":"57","author":"A Barac","year":"2019","unstructured":"Barac A, Kosmidis C, Alastruey-Izquierdo A, Salzer HJF, CPAnet. Chronic pulmonary aspergillosis update: a year in review. Med Mycol. 2019;57(Supplement_2):S104\u20139. https:\/\/doi.org\/10.1093\/mmy\/myy070.","journal-title":"Med Mycol"},{"issue":"165","key":"781_CR3","doi-asserted-by":"publisher","first-page":"16513","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):16513. https:\/\/doi.org\/10.1126\/scitranslmed.3004404.","journal-title":"Sci Transl Med."},{"issue":"1","key":"781_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","volume":"47","author":"DW Denning","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45\u201368. https:\/\/doi.org\/10.1183\/13993003.00583-2015.","journal-title":"Eur Respir J"},{"issue":"2","key":"781_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000489474","volume":"96","author":"A Alastruey-Izquierdo","year":"2018","unstructured":"Alastruey-Izquierdo A, Cadranel J, Flick H, et al. Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 2018;96(2):159\u201370. https:\/\/doi.org\/10.1159\/000489474.","journal-title":"Respiration"},{"issue":"1","key":"781_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00705-08","volume":"53","author":"D Andes","year":"2009","unstructured":"Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009;53(1):24\u201334. https:\/\/doi.org\/10.1128\/AAC.00705-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"781_CR7","first-page":"163","volume":"51","author":"JM Poirier","year":"1996","unstructured":"Poirier JM, Berlioz F, Isnard F, Cheymol G. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations. Therapie. 1996;51(2):163\u20137.","journal-title":"Therapie"},{"issue":"5","key":"781_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jac\/dkt508","volume":"69","author":"HR Ashbee","year":"2014","unstructured":"Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162\u201376. https:\/\/doi.org\/10.1093\/jac\/dkt508.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"781_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/AAC.37.4.778","volume":"37","author":"JA Barone","year":"1993","unstructured":"Barone JA, Koh JG, Bierman RH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother. 1993;37(4):778\u201384. https:\/\/doi.org\/10.1128\/AAC.37.4.778.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"781_CR10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/j.1875-9114.1996.tb02973.x","volume":"16","author":"VJ Van de Velde","year":"1996","unstructured":"Van de Velde VJ, Van Peer AP, Heykants JJ, et al. Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole. Pharmacotherapy. 1996;16(3):424\u20138.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"781_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1592\/phco.19.8.603.31529","volume":"19","author":"DA Stevens","year":"1999","unstructured":"Stevens DA. Itraconazole in cyclodextrin solution. Pharmacotherapy. 1999;19(5):603\u201311. https:\/\/doi.org\/10.1592\/phco.19.8.603.31529.","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"781_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u201338. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"781_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/jcp.50.6.477","volume":"50","author":"JD Cartledge","year":"1997","unstructured":"Cartledge JD, Midgely J, Gazzard BG. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis. J Clin Pathol. 1997;50(6):477\u201380. https:\/\/doi.org\/10.1136\/jcp.50.6.477.","journal-title":"J Clin Pathol"},{"issue":"11\u201312","key":"781_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1439-0507.1999.00518.x","volume":"42","author":"A Glasmacher","year":"1999","unstructured":"Glasmacher A, Hahn C, Molitor E, Marklein G, Sauerbruch T, Schmidt-Wolf IG. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules. Mycoses. 1999;42(11\u201312):591\u2013600. https:\/\/doi.org\/10.1046\/j.1439-0507.1999.00518.x.","journal-title":"Mycoses"},{"issue":"5","key":"781_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/17512433.2019.1604218","volume":"12","author":"K Sardana","year":"2019","unstructured":"Sardana K, Khurana A, Gupta A. Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses. Expert Rev Clin Pharmacol. 2019;12(5):443\u201352. https:\/\/doi.org\/10.1080\/17512433.2019.1604218.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"7","key":"781_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/09546634.2019.1708848","volume":"32","author":"K Sardana","year":"2021","unstructured":"Sardana K, Khurana A, Panesar S, Singh A. An exploratory pilot analysis of the optimal pellet number in 100 mg of itraconazole capsule to maximize the surface area to satisfy the Noyes-Whitney equation. J Dermatol Treat. 2021;32(7):788\u201394. https:\/\/doi.org\/10.1080\/09546634.2019.1708848.","journal-title":"J Dermatol Treat"},{"issue":"6","key":"781_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/idoj.IDOJ_339_17","volume":"9","author":"K Sardana","year":"2018","unstructured":"Sardana K, Khurana A, Singh A, Gautam RK. A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario. Indian Dermatol Online J. 2018;9(6):426\u201331. https:\/\/doi.org\/10.4103\/idoj.IDOJ_339_17.","journal-title":"Indian Dermatol Online J"},{"issue":"12","key":"781_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/myc.13367","volume":"64","author":"A Khurana","year":"2021","unstructured":"Khurana A, Agarwal A, Singh A, et al. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris\u2014a prospective trial. Mycoses. 2021;64(12):1480\u20138. https:\/\/doi.org\/10.1111\/myc.13367.","journal-title":"Mycoses"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-023-00781-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T17:19:52Z","timestamp":1702919992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-023-00781-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s11046-023-00781-7","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors whose names are listed above certify that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}